Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;103(6):1083-1091.
doi: 10.1111/aogs.14818. Epub 2024 Mar 19.

Cannabis exposure during pregnancy and perinatal outcomes: A cohort study

Maia Brik  1 , Miguel Sandonis  2   3 , Alina Hernández-Fleury  1 , Judit Gil  1 , Miriam Mota  4 , Francisco José Barranco  1 , Itziar Garcia  1 , Nerea Maiz  1 , Elena Carreras  1
Affiliations

Cannabis exposure during pregnancy and perinatal outcomes: A cohort study

Maia Brik et al. Acta Obstet Gynecol Scand. 2024 Jun.

Abstract

Introduction: Cannabis potency and its use during pregnancy have increased in the last decade. The aim of this study was to investigate the impact of antenatal cannabis use on fetal growth, preterm birth and other perinatal outcomes.

Material and methods: A propensity score-matched analysis was performed in women with singleton pregnancies attending a tertiary care site in Barcelona. Women in the cannabis group were selected based on the results of a detection test. Primary outcomes were small for gestational age at birth (SGA), low birthweight and preterm birth. Secondary outcomes were other biometric parameters (neonatal length and head circumference), respiratory distress, admission to the neonatal intensive care unit and breastfeeding at discharge. A second propensity score-matched analysis excluding other confounders (use of other recreational drugs and discontinuation of cannabis use during pregnancy) was performed.

Results: Antenatal cannabis was associated with a higher odds ratio of SGA (OR 3.60, 95% CI: 1.68-7.69), low birthweight (OR 3.94, 95% CI: 2.17-7.13), preterm birth at 37 weeks (OR 2.07, 95% CI: 1.12-3.84) and 32 weeks of gestation (OR 4.13, 95% CI: 1.06-16.11), admission to the neonatal intensive care unit (OR 1.95, 95% CI: 1.03-3.71), respiratory distress (OR 2.77, 95% CI: 1.26-6.34), and lower breastfeeding rates at discharge (OR 0.10, 95% CI: 0.05-0.18). When excluding other confounders, no significant association between antenatal cannabis use and SGA was found.

Conclusions: Antenatal cannabis use increases the risk of SGA, low birthweight, preterm birth and other adverse perinatal outcomes. However, when isolating the impact of cannabis use by excluding women who use other recreational drugs and those who discontinue cannabis during pregnancy, no significant association between antenatal cannabis use and SGA birth was found.

Keywords: birthweight; cannabis; fetal growth; preterm birth; recreational drugs; small for gestational age.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Figures

FIGURE 1
FIGURE 1
Patient flow diagram.
FIGURE 2
FIGURE 2
Standardized differences between the cannabis and control groups before and after propensity score matching.
FIGURE 3
FIGURE 3
Associations between antenatal cannabis use and the main outcomes.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Lozano J, García‐Algar O, Marchei E, et al. Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. Acta Paediatr. 2007;96:1734‐1737. - PubMed
    1. Volkow ND, Han B, Compton WM, McCance‐Katz EF. Self‐reported medical and nonmedical cannabis use among pregnant women in the United States. Jama. 2019;322:167. - PMC - PubMed
    1. ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995–2014): analysis of current data in the United States. Biol Psychiatry. 2016;79:613‐619. - PMC - PubMed
    1. Arzimanoglou A, Brandl U, Cross JH, et al. Epilepsy and cannabidiol: a guide to treatment. Epileptic Disor. 2020;22:1‐14. - PubMed
    1. Singh S, Filion K, Abenhaim H, Eisenberg M. Prevalence and outcomes of prenatal recreational cannabis use in high‐income countries: a scoping review. BJOG. 2020;127:8‐16. - PubMed